We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Reneuron Group Plc | LSE:RENE | London | Ordinary Share | GB00BF5G6K95 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.05 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 530k | -5.41M | -0.0946 | -0.32 | 1.74M |
Date | Subject | Author | Discuss |
---|---|---|---|
02/11/2022 09:43 | Just having a look. Can the cash burn here be reduced ? | wisecat2 | |
16/10/2022 10:35 | You argument would have more force if it were less silly. The management surely have little to be proud about (although recent changes have improved matters), and cash is always an issue in biotech, but exosomes are a key drug delivery platform for which Rene already has several collaborators. The recent results in glioblastoma were excellent. I'd be surprised if there weren't more in the future. | supernumerary | |
16/10/2022 08:28 | Anyone investing in the pedestrian clowns running this pedestrian outfit needs their head examined, either that or they just want to lose money. What’s the bull case? At best they might get someone to buy into their “delivery platform” waffle. Honestly? The whole reason people take a risk on biotech and drug companies is because they might find the next wonder drug of cure for cancer. But this lot have given up on that dream. So the reward dosen’t seem that good for the risk you are taking. Then there’s the simple fact they need cash by mid 2023 at the latest. Given their record of failure and burning millions of pounds of investors cash, it’s unlikely that anyone will advance them any money, so you are looking at bucket shop brokers massive equity placing, and they will want a massive discount and loads of warrants to boot. If you think these clowns will make a massive scientific breakthrough before then, perhaps wait, but history suggests that knack all will be forthcoming. | terminator101 | |
10/10/2022 13:54 | Spread of 7.4% . | snowy20 | |
10/10/2022 13:52 | 4 trades at this time -3 sells to 1 purchase . | snowy20 | |
10/10/2022 13:49 | digger2720 Sep '10 - 13:04 - 4 of 8390 0 0 0 Norbus - what is your gripe!!! The share price has gone up by an enormous 5% and propelled the bid into smidge orbit. Not bad for a company on the cusp of what could be the biggest breakthrough in medical science since Louis Pasteur!!! Personally I think the share price reacted to this new thread being set up so, if we each set up another new thread every day for the next 6 months we may see 10p if we are lucky. I remember DS were well over £1 a few years back and here we are at trial stage with a shameful share price at the mercy of the men in suits. ----- noTbaD CANtIS reVisiT 10p??? | andymunchkin | |
07/10/2022 08:47 | RENE today data points to effectiveness of its ground breaking technology, EXCELLENT | blackhorse23 | |
07/10/2022 08:43 | https://www.londonst | blackhorse23 | |
07/10/2022 08:03 | Excellent RNS | blackhorse23 | |
07/10/2022 07:27 | Seems that jetting scientists around the world to conferences and producing posters is what constitutes news in this pedestrian fluff. The band may have changed but the tune remains the same. Zzzzzzzzzzzz | terminator101 | |
22/9/2022 13:53 | probably needs another placing if funds run away ? | blackhorse23 | |
22/9/2022 08:35 | Oh look. The pedestrian scientists are going to yet another conference. zzzzzzzzzzzzzz | terminator101 | |
17/9/2022 17:18 | Checking In on this pedestrian pish. Zzzzzzzzzzzzzzzzzzzz Par for the course. Cash runway only extends to mid 2023 so in the earl6 part of next year they are going to have to raise money. With a record of failure like theirs, no way anyone will lend them cash IMO so another massive dilution equity raise will be the order of the day. | terminator101 | |
16/9/2022 08:53 | Excellent profit margin MCL (LSE) by 500% | blackhorse23 | |
14/9/2022 14:57 | new appointments today is this last chance saloon? | fred177 | |
06/9/2022 16:41 | amen to that no, cant see a return, just try and get a good price | martinfrench | |
02/9/2022 14:45 | 10 years? Wow. You are a patient man. Hopefully you will be rewarded for that one day too. I did not think much of the previous incumbent, but I liked the look of Iain and that in part led to my taking a small punt here. Anyway, I thought he was clear that there would be no raise, rather funds achieved via different means? Not that I take too seriously the words of AIM directors :) | lovewinshatelosses | |
02/9/2022 14:31 | cant see it, only a tax loss vehicle for me, and been here for well over 10 years | martinfrench | |
02/9/2022 13:37 | Maybe Martin, and I only bought a very small amount here for a punt not long ago, but at least Iain has put his hand in his pocket, unlike so many similar directors in outfits in this space. I hope he makes a sizeable profit from the 100K shares he bought very soon! GLA. | lovewinshatelosses | |
02/9/2022 11:52 | so price will be ramped up to help a rights issue i expect, well i for one wont fall for it they act like the public sector, just spend our money and dont care what the outcome is | martinfrench | |
02/9/2022 11:06 | I think they need funding again , 2022 August now | blackhorse23 | |
22/8/2022 12:31 | Guess investors weren't that impressed with the latest proactive interview huh. As per normal for this shower of pedestrian scientists nothing happening here quickly. Zzzzzzzzz | terminator101 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions